Accelerating COVID-19 Vaccination Among People Living With HIV and Health Care Workers in Tanzania: A Case Study.
Autor: | Jalloh MF; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania. yum8@cdc.gov., Tinuga F; Immunization and Vaccine Development, Tanzania Ministry of Health, Dar es Salaam, Tanzania., Dahoma M; Zanzibar Integrated HIV, Hepatitis, TB and Leprosy Program, Zanzibar, Tanzania., Rwebembera A; National AIDS Control Programme, Tanzania Ministry of Health, Dodoma, Tanzania., Kapologwe NA; President's Office - Regional Administration and Local Government, Dodoma, Tanzania., Magesa D; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Mukurasi K; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Rwabiyago OE; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Kazitanga J; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Miller A; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Sando D; Management and Development for Health, Dar es Salaam, Tanzania., Maruyama H; Tanzania Country Office, ICAP at Columbia University, Dar es Salaam, Tanzania., Mbatia R; Tanzania Health Promotion Support, Dar es Salaam, Tanzania., Temu F; Tanzania Country Office, Amref Health Africa, Dar es Salaam, Tanzania., Matiko E; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Kazaura K; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Njau P; National AIDS Control Programme, Tanzania Ministry of Health, Dodoma, Tanzania., Imaa J; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Pinto T; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Nur SA; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Schaad N; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Malero A; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Damian D; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Grund J; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Mgomella GS; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Johnson A; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Cole G; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Mmari E; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Gatei W; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Swaminathan M; Tanzania Country Office, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania. |
---|---|
Jazyk: | angličtina |
Zdroj: | Global health, science and practice [Glob Health Sci Pract] 2024 Jun 27; Vol. 12 (3). Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024). |
DOI: | 10.9745/GHSP-D-23-00281 |
Abstrakt: | Background: There is limited evidence on COVID-19 vaccination uptake among people living with HIV (PLHIV) and health care workers (HCWs), with the current evidence concentrated in high-income countries. There is also limited documentation in the published literature regarding the feasibility and lessons from implementing targeted vaccination strategies to reach PLHIV and HCWs in low- and middle-income countries. Program Development, Piloting, and Implementation: We designed and implemented multifaceted strategies to scale up targeted COVID-19 vaccination among PLHIV and HCWs in 11 administrative regions on the mainland of Tanzania plus Zanzibar. An initial 6-week intensification strategy was implemented using a diverse partnership model comprising key stakeholders at the national- and subnational levels. A layered package of strategies included expanding the number of certified vaccinators, creating vaccination points within HIV clinics, engaging HCWs to address their concerns, and building the capacity of HCWs as "champions" to promote and facilitate vaccination. We then closely monitored COVID-19 vaccination uptake in 562 high-volume HIV clinics. Between September 2021 and September 2022, the proportion of fully vaccinated adult PLHIV increased from <1% to 97% and fully vaccinated HCWs increased from 23% to 80%. Lessons and Implications: Our intra-action review highlighted the importance of leveraging a strong foundation of existing partnerships and platforms, integrating COVID-19 vaccination points within HIV clinics, and refining strategies to increase vaccination demand while ensuring continuity of vaccine supply to meet the increased demand. Lessons from Tanzania can inform targeted vaccination of vulnerable groups in future health emergencies. (© Jalloh et al.) |
Databáze: | MEDLINE |
Externí odkaz: |